Kiek dividendų moka Carl Zeiss Meditec 2025?
Pagal paskutinę informaciją nuo Sausis 2025, Carl Zeiss Meditec per paskutinius 12 mėnesių mokėjo bendrą dividendą, kuris sudarė 2,20 EUR už akciją. Esant dabartiniam Carl Zeiss Meditec kursui 48,24 EUR, tai atitinka 4,56 % dividendų grąžą.
Dividendai mokami 1 kartus per metus.
4,56 % Dividendo grąža | = | 2,20 EUR Dividendas | 48,24 EUR akcijų kaina |
|
Ar Carl Zeiss Meditec dividendai yra saugūs?
Carl Zeiss Meditec kasmet didina dividendus jau 2 metus.
Per pastaruosius 10 metus Carl Zeiss Meditec kasmet 17,198 % padidėjo.
Per 5 metų laikotarpį augo išmokos padidėjo 31,951 %.
Analitikai prognozuoja, kad einamaisiais verslo metais Dividendų didinimas bus 5,108%.
Carl Zeiss Meditec Aktienanalyse
Ką daro Carl Zeiss Meditec?
Carl Zeiss Meditec AG is a globally leading provider of medical technologies and devices for diagnostics and therapy. The company's history dates back to the founding of Carl Zeiss in 1846 in Jena, Germany. It has a long tradition in the development and manufacture of optical devices, particularly microscopes and binoculars.
In 1996, Carl Zeiss decided to spin off its medical technology business segment and establish Carl Zeiss Meditec AG. Since then, the company has developed a wide portfolio of products used in ophthalmology and other medical fields.
The business model of Carl Zeiss Meditec is based on three pillars: devices for diagnostics and therapy, software, and services. The devices are offered in various divisions specialized in specific application areas.
The ophthalmology division is the largest and most well-known area of the company. It offers a wide range of diagnostic and therapy devices used in the treatment of eye diseases such as glaucoma, cataract, and retinal disorders. The products of the ophthalmology division include OCT systems (optical coherence tomography) for detailed examination of the retina, as well as VisuMax laser technology for correction of vision defects.
Another important area of Carl Zeiss Meditec is the neurosurgery division. It offers devices for stereotactic neurosurgery used in the treatment of brain tumors, movement disorders, and other neurological conditions. The products of this division include the Kinevo stereotactic navigation system and the OPMI Neuro/NC4 surgical microscope series.
In the dental division, Carl Zeiss Meditec provides innovative solutions for dentistry. This includes optical impression systems (Artemis), CAD/CAM systems, and dental microscopes.
In addition to products, Carl Zeiss Meditec also offers software solutions for medical imaging and data processing. The FORUM software platform allows for intuitive management of medical images and findings. The company also provides training and education for doctors and medical professionals.
The products of Carl Zeiss Meditec are known for their high quality, reliability, and precision. The company focuses on innovative technologies and continuously invests in research and development to strengthen its position as a market leader in the medical technology industry.
Carl Zeiss Meditec is present in more than 60 countries worldwide and employs around 3,000 people. It is headquartered in Jena, Germany, and has additional locations in the United States, Canada, China, India, and other countries.
Overall, Carl Zeiss Meditec AG is an innovative and reliable partner for the medical technology industry. Its wide range of products and services contributes to improving the health of millions of people worldwide. Carl Zeiss Meditec yra viena populiariausių įmonių Eulerpool.com svetainėje.Akcijų taupymo planai siūlo patrauklią galimybę investuotojams ilgalaikėje perspektyvoje kurti turtą. Vienas pagrindinių privalumų yra vadinamasis vidutinės išlaidos efektas: reguliariai investuojant fiksuotą sumą į akcijas arba akcijų fondus, automatiškai perkama daugiau dalinių vertybių popierių, kai kainos yra žemos, ir mažiau – kai jos aukštos. Tai gali lemti palankesnę vidutinę dalies kainą per laiką. Be to, akcijų taupymo planai suteikia galimybę ir smulkiesiems investuotojams patekti į brangias akcijas, nes jie gali dalyvauti jau su mažomis sumomis. Reguliarus investavimas taip pat skatina disciplinuotą investavimo strategiją ir padeda išvengti emociškai pagrįstų sprendimų, pavyzdžiui, impulsyvaus pirkimo ar pardavimo. Be to, investuotojai gauna naudos iš potencialaus akcijų vertės augimo bei iš dividendų, kurie gali būti reinvestuoti, kas sustiprina sudėtinio palūkanų efektą ir taip skatina investuoto kapitalo augimą.
Carl Zeiss Meditec akcija yra taupoma šiuose teikėjuose: Trade Republic ir Consorsbank